TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T02653	HUMAN mineralocorticoid receptor	B6I4DM	(3R)-3-[1-(4-Fluorophenyl)indazol-5-yl]-2,2-dimethyl-3-phenyl-N-(1,3,4-thiadiazol-2-yl)propanamide	Investigative	72188915	C26H22FN5OS	471.6	CC(C)([C@H](C1=CC=CC=C1)C2=CC3=C(C=C2)N(N=C3)C4=CC=C(C=C4)F)C(=O)NC5=NN=CS5	EC50 > 5000000 nM	Non binder
T02653	HUMAN mineralocorticoid receptor	BD4WL5	(3S)-3-[1-(4-Fluorophenyl)indazol-5-yl]-2,2-dimethyl-3-phenyl-N-(1,3,4-thiadiazol-2-yl)propanamide	Investigative	72188914	C26H22FN5OS	471.6	CC(C)([C@@H](C1=CC=CC=C1)C2=CC3=C(C=C2)N(N=C3)C4=CC=C(C=C4)F)C(=O)NC5=NN=CS5	EC50 > 5000000 nM	Non binder
T02653	HUMAN mineralocorticoid receptor	BWO9E2	Lecanindole B	Investigative	44605898	C23H29NO2	351.5	C[C@]12CCC(=O)C([C@@]1(CC[C@@H]3[C@@]2(C4=C(C3)C5=CC=CC=C5N4)C)O)(C)C	IC50 > 10000000 nM	Non binder
T02653	HUMAN mineralocorticoid receptor	D0F1SS	Lecanindole D	Investigative	44605900	C23H31NO2	353.5	C[C@]12CC[C@H](C([C@@]1(CC[C@@H]3[C@@]2(C4=C(C3)C5=CC=CC=C5N4)C)O)(C)C)O	IC50 > 3000000 nM	Non binder